The R&D Value Cycle of Nano-Enabled Medical Devices – The Case of Biosensors
Nano-enabled devices leverage two general phenomena that occur at the nano-scale: (a) transitions in physiochemical properties, and (b) transitions in biochemical interactions. Evidently, the R&D value cycle is very scientist-driven, revolving around university departments generating new opportu...
Main Author: | C.G. Siontorou |
---|---|
Format: | Article |
Language: | English |
Published: |
AIDIC Servizi S.r.l.
2014-08-01
|
Series: | Chemical Engineering Transactions |
Online Access: | https://www.cetjournal.it/index.php/cet/article/view/5375 |
Similar Items
-
Nano-enabled medical devices based on biosensing principles: technology basis and new concepts
by: Christina G. Siontorou, et al.
Published: (2017-02-01) -
Study of Silicon Nano-electronic Devices as biosensor and gas sensor
by: Lin, Ru-Zheng, et al.
Published: (2018) -
trackeR: Infrastructure for Running and Cycling Data from GPS-Enabled Tracking Devices in R
by: Hannah Frick, et al.
Published: (2017-12-01) -
Nanobodies as novel agents for disease diagnosis and therapy
by: Siontorou CG
Published: (2013-11-01) -
Zinc oxide nano-rods based glucose biosensor devices fabrication
by: H.A. Wahab, et al.
Published: (2018-06-01)